MERLE L MYERSON

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease LEBANON, NH NPI 1801845359

General Payments — all program years on this page

$21,172.86

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 29
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,647.85 across 7 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $3,632.356
Esperion Therapeutics, Inc. $15.501

By program year

Program yearAmountRecords
2018 $6,039.687
2019 $3,596.775
2022 $500.001
2023 $7,388.569
2024 $3,647.857

Records — PY2024 (7)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087115182 Novartis Pharmaceuticals Corporation $700.00 01/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1087115204 Novartis Pharmaceuticals Corporation $700.00 03/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1087115206 Novartis Pharmaceuticals Corporation $700.00 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1087115214 Novartis Pharmaceuticals Corporation $700.00 05/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1087115216 Novartis Pharmaceuticals Corporation $700.00 04/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1087115220 Novartis Pharmaceuticals Corporation $132.35 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129448048 Esperion Therapeutics, Inc. $15.50 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.